[HTML][HTML] MicroRNAs in cancer and cardiovascular disease

M Ilieva, R Panella, S Uchida - Cells, 2022 - mdpi.com
Although cardiac tumor formation is rare, accumulating evidence suggests that the two
leading causes of deaths, cancers, and cardiovascular diseases are similar in terms of …

Molecular basis and clinical implications of HIFs in cardiovascular diseases

Y Hu, H Lu, H Li, J Ge - Trends in Molecular Medicine, 2022 - cell.com
Oxygen maintains the homeostasis of an organism in a delicate balance in different tissues
and organs. Under hypoxic conditions, hypoxia-inducible factors (HIFs) are specific and …

Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors

LM Khachigian, RL Varcoe, T Suoranta… - … and Vascular Biology, 2023 - Am Heart Assoc
Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis,
which commonly impairs blood flow to the lower extremities. The prevalence of PAD is …

[HTML][HTML] The role of lymphangiogenesis in cardiovascular diseases and heart transplantation

RC Ji - Heart Failure Reviews, 2022 - Springer
Cardiac lymphangiogenesis plays an important physiological role in the regulation of
interstitial fluid homeostasis, inflammatory, and immune responses. Impaired or excessive …

[HTML][HTML] Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on …

AJ Leikas, S Ylä-Herttuala, JEK Hartikainen - International Journal of …, 2023 - mdpi.com
Adenoviral vectors are commonly used in clinical gene therapy. Apart from oncolytic
adenoviruses, vector replication is highly undesired as it may pose a safety risk for the …

AAV-mediated gene therapy for Sialidosis

D van de Vlekkert, H Hu, JA Weesner, LE Fremuth… - Molecular Therapy, 2023 - cell.com
Sialidosis (Mucolipidosis I) is a glycoprotein storage disease, clinically characterized by a
spectrum of systemic and neurological phenotypes. The primary cause of the disease is …

[HTML][HTML] Adenoviral VEGF-DΔN ΔC gene therapy for myocardial ischemia

J Pajula, J Lähteenvuo, M Lähteenvuo… - … in Bioengineering and …, 2022 - frontiersin.org
Background: Cardiovascular diseases are the leading cause of death globally. In spite of the
availability of improved treatments, there is still a large group of chronic ischemia patients …

[HTML][HTML] Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases

L Jiao, Z Sun, Z Sun, J Liu, G Deng… - … in Bioengineering and …, 2024 - frontiersin.org
Gene therapy is a technique that rectifies defective or abnormal genes by introducing
exogenous genes into target cells to cure the disease. Although gene therapy has gained …

Manipulating bioactivities of endothelial progenitor cell-derived exosomes for promoting angiogenesis in ischemic vascular diseases

B Dong, Y Qiu, Z Liu, J Huang, Z Wang, Q Tu, Z Zhou… - Nano Today, 2023 - Elsevier
Exosomes paracrine-secreted by EPC (EPC-EXO) may exert strong pro-angiogenic effects,
which offers a potential means to treat ischemic diseases. However, the mechanism of EPC …

[HTML][HTML] Recent advances in gene therapy for cardiac tissue regeneration

Y Kim, Z Zharkinbekov, M Sarsenova, G Yeltay… - International journal of …, 2021 - mdpi.com
Cardiovascular diseases (CVDs) are responsible for enormous socio-economic impact and
the highest mortality globally. The standard of care for CVDs, which includes medications …